GENE ONLINE|News &
Opinion
Blog

AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan

by Joy Lin
Share To
Japan has granted marketing approvals to AstraZeneca’s Kosulego (selumetinib) and Tezspire (tezepelumab), treatments for plexiform neurofibromas (PNs) in neurofibromatosis type 1 (NF1) and severe asthma respectively. 

The approval of Kosulego, given by the Japanese Ministry of Health, Labor and Welfare (MHLW), makes it the first and only approved treatment for the treatment of children aged 3 years and older with PNs in NF1, a rare genetic condition that affects nerve tissue. Kosulego won US FDA approval for PNs in NF1 in April 2020, which was followed by a nod from the EU in June 2021. The drug is being developed as part of a massive $8.5 billion partnership between AstraZeneca and Merck (known outside the US and Canada as MSD). 

GO Prime with only $1.49 now

LATEST
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
Scroll to Top